Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LRMR
- Price
- 1.81
- Stock movement up
- +0.03 (1.69%)
- Company name
- Larimar Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 115.49M
- Ent value
- 101.04M
- Price/Sales
- -
- Price/Book
- 0.58
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -48.33%
- 1 year return
- -73.54%
- 3 year return
- -23.03%
- 5 year return
- -27.44%
- 10 year return
- -42.04%
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
LRMR does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.58 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 63.81M |
| EPS (TTM) | -1.02 |
| FCF per share (TTM) | -0.92 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -322.00K |
| Operating income (TTM) | -73.76M |
| Net income (TTM) | -64.77M |
| EPS (TTM) | -1.02 |
| EPS (1y forward) | -1.66 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 35.07M |
| Net receivables | 943.00K |
| Total current assets | 213.26M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 5.27M |
| Total assets | 219.02M |
| Accounts payable | 1.69M |
| Short/Current long term debt | 5.36M |
| Total current liabilities | 16.29M |
| Total liabilities | 20.62M |
| Shareholder's equity | 198.40M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -58.29M |
| Capital expenditures (TTM) | 500.00K |
| Free cash flow (TTM) | -58.79M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -32.65% |
| Return on Assets | -29.57% |
| Return on Invested Capital | -32.31% |
| Cash Return on Invested Capital | -29.33% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.77 |
| Daily high | 1.86 |
| Daily low | 1.73 |
| Daily Volume | 544K |
| All-time high | 616.08 |
| 1y analyst estimate | 20.67 |
| Beta | 0.71 |
| EPS (TTM) | -1.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 7 May 2025 |
Downside potential
Loading...
Downside potential data
| LRMR | S&P500 | |
| Current price drop from All-time high | -99.71% | -12.89% |
| Highest price drop | -99.75% | -56.47% |
| Date of highest drop | 5 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -85.28% | -11.07% |
| Avg time to new high | 94 days | 12 days |
| Max time to new high | 2533 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
115.49M
Marketcap category
Small-cap
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.
Employees
42
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page